OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

GILEAD SCIENCES DL-,001/  US3755581036  /

Berlin
2024-12-20  8:08:19 AM Chg. +0.27 Volume Bid8:59:50 PM Ask8:59:50 PM Market Capitalization Dividend Y. P/E Ratio
87.36EUR +0.31% 0
Turnover: 0.00		 88.69Bid Size: 570 88.80Ask Size: 570 110.62 bill.EUR - -
GlobeNewswire 08-27 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
GlobeNewswire 08-27 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
GlobeNewswire 08-08 HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 08-08 Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates
GlobeNewswire 08-08 Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2024 Financial Results
GlobeNewswire 08-06 MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results
GlobeNewswire 08-05 89bio Reports Second Quarter 2024 Financial Results and Corporate Updates
GlobeNewswire 08-05 89bio Appoints Charles McWherter, Ph.D., to its Board of Directors
GlobeNewswire 08-01 Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update
GlobeNewswire 07-23 ACTG Presents Data Analysis at AIDS 2024 Showing Association between Elevated Risk of Cardiovascular...
GlobeNewswire 07-15 Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inh...
GlobeNewswire 07-08 Memo Therapeutics AG appoints Paul Carter as Chairperson
GlobeNewswire 07-08 Memo Therapeutics AG appoints Paul Carter as Chairperson
GlobeNewswire 07-04 Burns McClellan Mourns the Passing of Founder and CEO, Lisa Burns
GlobeNewswire 07-01 HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment o...
GlobeNewswire 07-01 Vera Therapeutics Announces Appointment of Industry Veteran David L. Johnson as Chief Operating Offi...
GlobeNewswire 06-28 Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire 06-26 Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
GlobeNewswire 06-26 Oruka Therapeutics Announces Key Additions to Leadership Team and Board of Directors
TeleTrader 06-20 US opens mostly higher after labor, housing data
GlobeNewswire 06-18 Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation C...
GlobeNewswire 06-17 Assembly Biosciences Announces $12.6 Million in Equity Financings
GlobeNewswire 06-10 Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus He...
GlobeNewswire 05-22 Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congres...
GlobeNewswire 05-14 Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results